BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9686376)

  • 1. X-linked adrenoleukodystrophy: improved prenatal diagnosis using both biochemical and immunological methods.
    Wanders RJ; Mooyer PW; Dekker C; Vreken P
    J Inherit Metab Dis; 1998 Jun; 21(3):285-7. PubMed ID: 9686376
    [No Abstract]   [Full Text] [Related]  

  • 2. The prenatal diagnosis of X-linked adrenoleukodystrophy.
    Moser AB; Moser HW
    Prenat Diagn; 1999 Jan; 19(1):46-8. PubMed ID: 10073906
    [No Abstract]   [Full Text] [Related]  

  • 3. Co-expression of mutated and normal adrenoleukodystrophy protein reduces protein function: implications for gene therapy of X-linked adrenoleukodystrophy.
    Unterrainer G; Molzer B; Forss-Petter S; Berger J
    Hum Mol Genet; 2000 Nov; 9(18):2609-16. PubMed ID: 11063720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adrenoleukodystrophy-related protein can compensate functionally for adrenoleukodystrophy protein deficiency (X-ALD): implications for therapy.
    Netik A; Forss-Petter S; Holzinger A; Molzer B; Unterrainer G; Berger J
    Hum Mol Genet; 1999 May; 8(5):907-13. PubMed ID: 10196381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ALDP expression in fibroblasts of patients with X-linked adrenoleukodystrophy.
    Kemp S; Mooyer PA; Bolhuis PA; van Geel BM; Mandel JL; Barth PG; Aubourg P; Wanders RJ
    J Inherit Metab Dis; 1996; 19(5):667-74. PubMed ID: 8892025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational analysis of an X-linked adrenoleukodystrophy (ALD) patient with detectable ALD protein.
    Jorge P; Brites P; Nogueira A; Aubourg P
    Ann N Y Acad Sci; 1996 Dec; 804():756-9. PubMed ID: 8993616
    [No Abstract]   [Full Text] [Related]  

  • 7. Suppression of peroxisomal membrane protein defects by peroxisomal ATP binding cassette (ABC) proteins.
    Braiterman LT; Zheng S; Watkins PA; Geraghty MT; Johnson G; McGuinness MC; Moser AB; Smith KD
    Hum Mol Genet; 1998 Feb; 7(2):239-47. PubMed ID: 9425230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protease inhibitors suppress the degradation of mutant adrenoleukodystrophy proteins but do not correct impairment of very long chain fatty acid metabolism in adrenoleukodystrophy fibroblasts.
    Yamada T; Shinnoh N; Kobayashi T
    Neurochem Res; 1997 Mar; 22(3):233-7. PubMed ID: 9051655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholesterol regulates ABCD2 expression: implications for the therapy of X-linked adrenoleukodystrophy.
    Weinhofer I; Forss-Petter S; Zigman M; Berger J
    Hum Mol Genet; 2002 Oct; 11(22):2701-8. PubMed ID: 12374760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. X-linked adrenoleukodystrophy: clinical, metabolic, genetic and pathophysiological aspects.
    Kemp S; Berger J; Aubourg P
    Biochim Biophys Acta; 2012 Sep; 1822(9):1465-74. PubMed ID: 22483867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. X-linked adrenoleukodystrophy.
    Aubourg P; Mandel JL
    Ann N Y Acad Sci; 1996 Dec; 804():461-76. PubMed ID: 8993565
    [No Abstract]   [Full Text] [Related]  

  • 12. Mouse models and genetic modifiers in X-linked adrenoleukodystrophy.
    Heinzer AK; McGuinness MC; Lu JF; Stine OC; Wei H; Van der Vlies M; Dong GX; Powers J; Watkins PA; Smith KD
    Adv Exp Med Biol; 2003; 544():75-93. PubMed ID: 14713218
    [No Abstract]   [Full Text] [Related]  

  • 13. Adrenoleukodystrophy.
    Moser HW
    Curr Opin Neurol; 1995 Jun; 8(3):221-6. PubMed ID: 7551122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adrenoleukodystrophy and other peroxisomal diseases.
    Aubourg P
    Curr Opin Genet Dev; 1994 Jun; 4(3):407-11. PubMed ID: 7919919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. X-linked adrenoleukodystrophy in children: review of genetic, clinical, and MR imaging characteristics.
    Melhem ER; Barker PB; Raymond GV; Moser HW
    AJR Am J Roentgenol; 1999 Dec; 173(6):1575-81. PubMed ID: 10584804
    [No Abstract]   [Full Text] [Related]  

  • 16. First trimester prenatal diagnosis of adrenoleukodystrophy by determination of very long chain fatty acid levels and by linkage analysis to a DNA probe.
    Boué J; Oberle I; Heilig R; Mandel JL; Moser A; Moser H; Larsen JW; Dumez Y; Boué A
    Hum Genet; 1985; 69(3):272-4. PubMed ID: 3856557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a new frameshift mutation (1801delAG) in the ALD gene.
    Barceló A; Girós M; Sarde CO; Martínez-Bermejo A; Mandel JL; Pàmpols T; Estivill X
    Hum Mol Genet; 1994 Oct; 3(10):1889-90. PubMed ID: 7849718
    [No Abstract]   [Full Text] [Related]  

  • 18. On the front of X-linked adrenoleukodystrophy.
    Aubourg P
    Neurochem Res; 1999 Apr; 24(4):515-20. PubMed ID: 10227684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prenatal diagnosis of X-linked adrenoleukodystrophy].
    Bao XH; Ping LL; Wang AH; Pan H; Wu Y; Xiong H; Zhang YH; Shi CY; Qin J; Wu X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Feb; 24(1):1-5. PubMed ID: 17285533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [X-linked adrenoleukodystrophy (ALD)].
    Imamura A
    Ryoikibetsu Shokogun Shirizu; 1998; (19 Pt 2):315-21. PubMed ID: 9645071
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.